摘要
世界上主要国家和地区对人胚胎干细胞相关专利申请的审查政策和审查标准存在很大不同,以美国为代表的一些国家实行宽松的专利授权标准,以欧洲和中国为代表的一些国家和地区实行伦理道德审查,对人胚胎干细胞相关主题排除在专利授权之外。通过与美国、欧洲、日本等国家和地区的专利保护情况进行典型案例对比分析,试图对于我国人胚胎干细胞专利法律保护提出一些理解和建议。
There are enormous controversies and disagreements in the patent examination policies in different countries and regions for human embryonic stem cell-related patent applications. Human embryonic stem cell-related topics are patentable in a number of countries such as USA but not in Europe and China, where strict ethical examination to human embryonic stem cell-related topics is implemented. In this paper, the typical cases from USA, EU, Japan and China are analyzed and compared. Accordingly, we are trying to put up some personal understanding and recommendations about patentability of human embryonic stem cell-related topics.
出处
《知识产权》
CSSCI
北大核心
2013年第5期52-57,共6页
Intellectual Property
关键词
人胚胎干细胞
伦理
专利
审查
human embryonic stem cell
ethics
patent
examination
